News Daily News Q&A: Lior Jankelson on AI Tools for Suspected ACS and More Todd Neale February 10, 2026
News Conference News AHA 2025 Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF Todd Neale November 17, 2025
News Conference News AHA 2025 DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation Todd Neale November 12, 2025
News Daily News AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER L.A. McKeown July 30, 2025
News Conference News NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months Yael L. Maxwell February 18, 2025
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Daily News LAAO During Cardiac Surgery May Help, Even in AF’s Absence Todd Neale September 17, 2024
News Conference News EHRA 2024 Study Bolsters AF’s Link to Brain Infarcts, Cognitive Impairment Todd Neale April 08, 2024
News Features A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed? Todd Neale January 25, 2024
News Daily News DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants Shelley Wood January 17, 2024
News Conference News AHA 2023 Simultaneous Dual Cardioversion of AF Lessens Failure Rates in Obese Patients Todd Neale November 14, 2023
News Conference News ESC 2023 DANPACE II: Reducing Atrial Pacing Doesn’t Prevent AF in Sinus Node Disease Todd Neale August 30, 2023
News Conference News EHRA 2023 Outcomes Just as Good With Delayed vs Early AF Ablation Michael O'Riordan April 17, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
News Conference News AHA 2022 Botulinum Toxin Injections No Help for Postoperative AF: NOVA Yael L. Maxwell November 07, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022